Publications

Correction: Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn's Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned? - Iago Rodríguez Lago

Rodríguez-Lago I, Peinado-Fabregat JI, Guigini M, Cerezales M, Ibáñez F, Crespo C, Barreiro-de Acosta M. Correction: Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn's Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned?. Pharmacoecon Open. 2026 May;10:591. doi:10.1007/s41669-026-00648-9. pmc:PMC13194901. PMID:42012591.

Date: 2026

Correction: Exploring lived experiences in home-based psychiatric care: a qualitative study of service users, families, and professionals in Spain. - Ana Maria Besoain Cornejo, MªMontserrat Gil Girbau

Besoaín-Cornejo AM, Gil-Girbau M, Alouali-Moussakhkhar M, Baladón Higueras L, Sáez J, Rubio-Valera M. Correction: Exploring lived experiences in home-based psychiatric care: a qualitative study of service users, families, and professionals in Spain.. Front Psychiatry. 2026 ;17:1783795. doi:10.3389/fpsyt.2026.1783795. Epub 2026 Jan 16. pmc:PMC12857306. PMID:41623550.

Date: 2026

Corrigendum to "Prevalence, risk factors, and prognosis of the need for physical and chemical restraint in older patients attending emergency departments. EDEN-50" [American Journal of Emergency Medicine 105C (2026) 79-87]. - Juan Gonzalez Del Castillo

Llorens P, Cano S, Espinosa B, Villar M, Pastor Bellod E, Miró Ò, González Del Castillo J, Ramos-Rincón JM, . Corrigendum to "Prevalence, risk factors, and prognosis of the need for physical and chemical restraint in older patients attending emergency departments. EDEN-50" [American Journal of Emergency Medicine 105C (2026) 79-87].. Am J Emerg Med. 2026 Jun;:. doi:10.1016/j.ajem.2026.05.039. Epub 2026 Jun 03. PMID:42236377.

Date: 2026

Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn's Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned? - Iago Rodríguez Lago

Rodríguez-Lago I, Peinado-Fabregat JI, Guigini M, Cerezales M, Ibáñez F, Crespo C, Barreiro-de Acosta M. Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn's Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned?. Pharmacoecon Open. 2026 May;10:557. doi:10.1007/s41669-026-00642-1. Epub 2026 Mar 09. pmc:PMC13194847. PMID:41803589.

Date: 2026

Cost-Effectiveness of Venom Immunotherapy in Preventing Severe Bee and Wasp Sting Reactions. - Carmen Vidal Pan

Sturm G, Bilò MB, Vidal C, Oude Elberink JNG, Schmitt J, Slættanes AK, Jakob T. Cost-Effectiveness of Venom Immunotherapy in Preventing Severe Bee and Wasp Sting Reactions.. Allergy. 2026 Apr;81:1228. doi:10.1111/all.70176. Epub 2025 Dec 18. pmc:PMC13040657. PMID:41410197.

Date: 2026

Costs of autism spectrum disorders and access to services in Spain. - Lidia García Pérez, Vanesa Ramos García, Renata Linertová -, Cristina Valcárcel Nazco, Martin Knapp -, Pedro Guillermo Serrano Aguilar

García-Pérez L, Ramos-García V, Linertová R, Valcárcel-Nazco C, Santos B, Canal-Bedia R, Iemmi V, Knapp M, Scattoni ML, Schendel D, Posada M, Serrano-Aguilar P. Costs of autism spectrum disorders and access to services in Spain.. BMC Health Serv Res. 2026 Jun;26:. doi:10.1186/s12913-026-14879-3. Epub 2026 Jun 04. pmc:PMC13459201. PMID:42243945.

Date: 2026

Criteria to prioritize clinical practice guideline recommendations for patient decision aid development: results from a modified Delphi consensus study. - Lilisbeth Perestelo Pérez, María del Mar Trujillo Martín

Schewe LV, Scheibler F, Fischer L, Baghus A, van Bostraeten P, Bresser C, Burgers JS, Conijn D, Dreesens D, Elwyn G, Forcino RC, Franco J, Garvelink M, Giguère A, Gionfriddo MR, Gupta S, Hoffmann T, van Leeuwen A, Maes-Carballo M, Munn Z, Peleg M, Perestelo-Pérez L, Schubbe D, Sprengers D, Stacey D, Stiggelbout A, Trujillo-Martín MM, van der Weele G, Florez ID, Hutchinson A, Li S, Puljak L, Karge T, Langer T, Orduhan C, Schaefer C, Pieper D. Criteria to prioritize clinical practice guideline recommendations for patient decision aid development: results from a modified Delphi consensus study.. J Clin Epidemiol. 2026 Jun;194:112229. doi:10.1016/j.jclinepi.2026.112229. Epub 2026 Mar 16. PMID:41850547.

Date: 2026

Cross-cultural adaptation and validation of the Diabetic Foot Questionnaire (DiaFootQ) into Spanish Language. - Francisco Javier Martinez Barrios, Manuel González Panzano

Ruiz-Muñoz M, Martínez-Barrios FJ, Fernández-Torres R, Vallejo-Herrera MJ, García-Campos J, González-Sánchez M. Cross-cultural adaptation and validation of the Diabetic Foot Questionnaire (DiaFootQ) into Spanish Language.. Aten Primaria. 2026 Jun;58:103491. doi:10.1016/j.aprim.2026.103491. Epub 2026 Apr 08. pmc:PMC13091101. PMID:41955669.

Date: 2026

Cultivating Compassion in Students for End-Of-Life Processes: A Mixed-Methods Participatory Research Protocol. - Rafaela Camacho Bejarano

Abad-Corpa E, Espinosa-Sánchez M, Barnestein-Fonseca P, Camacho-Bejarano R, Delgado-Hito P, Miró-Bonet R, . Cultivating Compassion in Students for End-Of-Life Processes: A Mixed-Methods Participatory Research Protocol.. J Adv Nurs. 2026 Jun;82:6872. doi:10.1111/jan.70235. Epub 2025 Oct 11. pmc:PMC13176715. PMID:41074876.

Date: 2026

Determinants of obesity: The role of sociodemographic factors, health behaviors, and quality of life in Spanish workers. - José Ignacio Ramirez Manent

Jansana MDM, López PJT, Miquel JJG, López-González ÁA, Sbert PR, Busquets-Cortés C, Ramírez-Manent JI. Determinants of obesity: The role of sociodemographic factors, health behaviors, and quality of life in Spanish workers.. Obes Res Clin Pract. 2026 ;20:185. doi:10.1016/j.orcp.2026.04.005. Epub 2026 May 13. PMID:42120236.

Date: 2026